News

The company will also rename the business Therapeutic Support Systems to better reflect the clinical value its therapies offer to caregivers and patients. Lynne Sly, who recently served

Fusion Capital has purchased 2.78 million shares together with a warrant to purchase up to 1.39 million shares of Dor common stock at $0.22 per share, for an

Initially consisting of 1800 antibodies, the library is expected to grow by several thousand per year with the goal of producing at least one antibody to all 22,000

The purchase agreement was completed in conjunction with the formation of a worldwide collaboration and licensing agreement with Pfizer for the discovery, development and commercialization of compounds which

Albireo has secured one clinical and a number of preclinical gastrointestinal (GI) programs from AstraZeneca as well as several researchers with extensive experience in AstraZeneca’s GI Research Area.

The company has divisionalized Signalcare for the time being, and will evaluate placing Signalcare into a wholly-owned subsidiary after developments and relationships have materialized or have become formalized.

Dendreon’s researchers evaluated cumulative product release parameters of Provenge, including CD54 upregulation (a measure of product potency defined as the increase of CD54 molecules expressed on Antigen Presenting

The plan also calls for the expansion of business development initiatives to evaluate partnership opportunities across the company’s product pipeline and the streamlining of operations through an expense-reduction

The notice of allowance is the USPTO’s official communication that the company’s application has successfully completed examination and that a patent will be issued. Once issued, the patent